Personalis Inc PSNL:NASDAQ

Last Price$3.71Cboe Real-Time Last Sale as of 1:22PM ET 7/06/22
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-0.02(0.54%)
Bid (Size)$3.71 (300)
Ask (Size)$3.72 (300)
Day Low / High$3.69 - 3.91
Volume274.9 K
 

View Biotechnology IndustryPeer Comparison as of 07/06/2022

 

Personalis Inc ( NASDAQ )

Price: $3.71
Change: -0.02 (0.54%)
Volume: 274.9 K
1:22PM ET 7/06/2022
 
 

CorMedix Inc ( NASDAQ )

Price: $4.06
Change: -0.26 (6.02%)
Volume: 305.0 K
1:24PM ET 7/06/2022
 
 

INmune Bio Inc ( NASDAQ )

Price: $9.65
Change: +0.37 (3.99%)
Volume: 66.0 K
1:03PM ET 7/06/2022
 
 

Jounce Therapeutics Inc ( NASDAQ )

Price: $3.14
Change: -0.03 (0.95%)
Volume: 61.2 K
1:18PM ET 7/06/2022
 
 

XBiotech Inc ( NASDAQ )

Price: $5.98
Change: +0.19 (3.28%)
Volume: 22.8 K
12:21PM ET 7/06/2022
 

Read more news Recent News

--Citigroup Adjusts Personalis' Price Target to $14 from $18, Keeps Buy Rating
1:21PM ET 5/05/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--HC Wainwright Adjusts Personalis' Price Target to $30 From $38, Reiterates Buy Rating
7:16AM ET 5/05/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

-- Earnings Flash (PSNL) PERSONALIS Reports Q1 Revenue $15.2M, vs. Street Est of $14.4M
4:05PM ET 5/04/2022 MT Newswires

...

Evaxion Biotech to Use Personalis Platform to Evaluate Efficacy of Skin Cancer Combination Therapy
10:56AM ET 4/26/2022 MT Newswires

Evaxion Biotech (EVAX) will use Personalis's (PSNL) ImmunoID NeXT platform in a phase 2b trial to assess the efficacy and safety of its EVX-01 personalized...

View all Commentary and Analysis

The Prognosis For Personalis
12:41PM ET 6/16/2022 Seeking Alpha

Liquid Biopsy: A Pathway To Earlier And Less Invasive Cancer Detection
4:30AM ET 5/25/2022 Seeking Alpha

Personalis, Inc.'s (PSNL) CEO John West on Q1 2022 Results - Earnings Call Transcript
11:44PM ET 5/04/2022 Seeking Alpha

Personalis (PSNL) Investor Presentation - Slideshow
12:23PM ET 4/14/2022 Seeking Alpha

Company Profile

Business DescriptionPersonalis, Inc. engages in the provision of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in 2011 and is headquartered in Menlo Park, CA. View company web site for more details
Address1330 O'Brien Drive
Menlo Park, California 94025
Phone+1.650.752.1300
Number of Employees139
President, Chief Executive Officer & DirectorJohn S. West
Chief Financial Officer & Senior Vice PresidentAaron Tachibana
Chief Medical Officer, SVP-Research & DevelopmentRichard O. Chen
Vice President-Immunology, Research & DevelopmentXavier Paliard

Company Highlights

Price Open$3.70
Previous Close$3.73
52 Week Range$3.13 - 25.20
Market Capitalization$168.6 M
Shares Outstanding45.4 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement08/03/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.81
Beta vs. S&P 500N/A
Revenue$37.8 M
Net Profit Margin-101.49%
Return on Equity-25.70%

Analyst Ratings as of 01/07/2022

Buy
6
Overweight
0
Hold
2
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset